These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 3593899)

  • 1. Pharmacokinetics of dexamethasone and its phosphate ester.
    Rohdewald P; Möllmann H; Barth J; Rehder J; Derendorf H
    Biopharm Drug Dispos; 1987; 8(3):205-12. PubMed ID: 3593899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of the bioavailability and potency of dexamethasone phosphate and sulphate in man.
    Miyabo S; Nakamura T; Kuwazima S; Kishida S
    Eur J Clin Pharmacol; 1981; 20(4):277-82. PubMed ID: 6273180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of prednisolone after high doses of prednisolone hemisuccinate.
    Derendorf H; Rohdewald P; Möllmann H; Rehder J; Barth J; Neveling D
    Biopharm Drug Dispos; 1985; 6(4):423-32. PubMed ID: 4084667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dexamethasone bovine pharmacokinetics.
    Gaignage P; Lognay G; Bosson D; Vertongen D; Dreze P; Marlier M; Severin M
    Eur J Drug Metab Pharmacokinet; 1991; 16(3):219-21. PubMed ID: 1814739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intratympanic versus intravenous delivery of dexamethasone and dexamethasone sodium phosphate to cochlear perilymph.
    Bird PA; Murray DP; Zhang M; Begg EJ
    Otol Neurotol; 2011 Aug; 32(6):933-6. PubMed ID: 21725263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dexamethasone in cattle: pharmacokinetics and action on the adrenal gland.
    Toutain PL; Brandon RA; Alvinerie M; Garcia-Villar R; Ruckebusch Y
    J Vet Pharmacol Ther; 1982 Mar; 5(1):33-43. PubMed ID: 7097848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioavailability of dexamethasone. II. Dexamethasone phosphate.
    Hare LE; Yeh KC; Ditzler CA; McMahon FG; Duggan DE
    Clin Pharmacol Ther; 1975 Sep; 18(3):330-7. PubMed ID: 1100302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dexamethasone concentrations in bovine blood plasma and milk after intravenous injection.
    Tainturier D; Alvinerie M; Brandon RA; Toutain PL
    J Dairy Sci; 1982 Oct; 65(10):1921-4. PubMed ID: 7174961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dexamethasone: pharmacokinetics in neurological patients.
    Eadie MJ; Brophy TR; Ohlrich G; Tyrer JH
    Clin Exp Neurol; 1984; 20():107-18. PubMed ID: 6568935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of dexamethasone pharmacokinetics in female rats after intravenous and intramuscular administration.
    Samtani MN; Jusko WJ
    Biopharm Drug Dispos; 2005 Apr; 26(3):85-91. PubMed ID: 15654687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dexamethasone suppression testing in chronic renal failure: pharmacokinetics of dexamethasone and demonstration of a normal hypothalamic-pituitary-adrenal axis.
    Workman RJ; Vaughn WK; Stone WJ
    J Clin Endocrinol Metab; 1986 Sep; 63(3):741-6. PubMed ID: 3734041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose-dependent pharmacokinetics of dexamethasone.
    Loew D; Schuster O; Graul EH
    Eur J Clin Pharmacol; 1986; 30(2):225-30. PubMed ID: 3709651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic intrathecal administration of dexamethasone sodium phosphate: pharmacokinetics and neurotoxicity in an animal model.
    Kroin JS; Schaefer RB; Penn RD
    Neurosurgery; 2000 Jan; 46(1):178-82; discussion 182-3. PubMed ID: 10626948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transdermal iontophoresis of dexamethasone sodium phosphate in vitro and in vivo: effect of experimental parameters and skin type on drug stability and transport kinetics.
    Cázares-Delgadillo J; Balaguer-Fernández C; Calatayud-Pascual A; Ganem-Rondero A; Quintanar-Guerrero D; López-Castellano AC; Merino V; Kalia YN
    Eur J Pharm Biopharm; 2010 Jun; 75(2):173-8. PubMed ID: 20332024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioavailability of oral dexamethasone during high dose steroid therapy in neurological patients.
    Brophy TR; McCafferty J; Tyrer JH; Eadie MJ
    Eur J Clin Pharmacol; 1983; 24(1):103-8. PubMed ID: 6832191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics and pharmacodynamics of dexamethasone sodium-m-sulfobenzoate (DS) after intravenous and intramuscular administration: a comparison with dexamethasone phosphate (DP).
    Hochhaus G; Barth J; al-Fayoumi S; Suarez S; Derendorf H; Hochhaus R; Möllmann H
    J Clin Pharmacol; 2001 Apr; 41(4):425-34. PubMed ID: 11304899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of triamcinolone acetonide and its phosphate ester.
    Möllmann H; Rohdewald P; Schmidt EW; Salomon V; Derendorf H
    Eur J Clin Pharmacol; 1985; 29(1):85-9. PubMed ID: 4054209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic study of dexamethasone disodium phosphate using intravitreal, subconjunctival, and intravenous delivery routes in rabbits.
    Hosseini K; Matsushima D; Johnson J; Widera G; Nyam K; Kim L; Xu Y; Yao Y; Cormier M
    J Ocul Pharmacol Ther; 2008 Jun; 24(3):301-8. PubMed ID: 18476800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetics of methylprednisolone and its hemisuccinate ester.
    Derendorf H; Möllmann H; Rohdewald P; Rehder J; Schmidt EW
    Clin Pharmacol Ther; 1985 May; 37(5):502-7. PubMed ID: 3886255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics and dose linearity testing of methylprednisolone phosphate.
    Möllmann H; Rohdewald P; Barth J; Verho M; Derendorf H
    Biopharm Drug Dispos; 1989; 10(5):453-64. PubMed ID: 2804250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.